Gao Q, Lin Y, Du Y, Du C
Cancer Manag Res. 2024; 16:1753-1758.
PMID: 39678042
PMC: 11646468.
DOI: 10.2147/CMAR.S491295.
Elghobashy M, Siafakas M, Elshafie M, Hejmadi R, Basu N, Shaaban A
Biomedicines. 2024; 12(6).
PMID: 38927449
PMC: 11201021.
DOI: 10.3390/biomedicines12061242.
Bonan P, Gallo G, Fusco I, Madeddu F, Zingoni T
J Med Cases. 2023; 14(7):251-254.
PMID: 37560545
PMC: 10409540.
DOI: 10.14740/jmc4132.
Cohen P, Kurzrock R
Cureus. 2023; 15(1):e33975.
PMID: 36824550
PMC: 9941027.
DOI: 10.7759/cureus.33975.
Qudaih A, Al Ashour B, Naim A, Joudeh A
Cureus. 2021; 13(7):e16642.
PMID: 34466316
PMC: 8396404.
DOI: 10.7759/cureus.16642.
A Case of Muir-Torre Syndrome.
Sheth R, Menon P, Malik D
Cureus. 2021; 13(4):e14582.
PMID: 34036002
PMC: 8136295.
DOI: 10.7759/cureus.14582.
Sebaceous carcinoma of the vulva: a case report and review of the literature.
Alharthi H, Alnuaim H, Aljarbou O, Arabi H
Avicenna J Med. 2021; 11(1):49-53.
PMID: 33520791
PMC: 7839268.
DOI: 10.4103/ajm.ajm_183_20.
A Case of External Auditory Canal Sebaceous Carcinoma: Literature Review and Treatment Discussion.
Saadi R, Pennock M, Baker A, Isildak H
Biomed Hub. 2020; 5(2):72-78.
PMID: 32775336
PMC: 7392381.
DOI: 10.1159/000508058.
[Recurrent eyelid tumors with different dignities].
Low U, Muller C, Zemova E, Flockerzi F, Seitz B
Ophthalmologe. 2019; 116(11):1083-1086.
PMID: 31254059
DOI: 10.1007/s00347-019-0928-9.
Ocular sebaceous gland carcinoma: an update of the literature.
Cicinelli M, Kaliki S
Int Ophthalmol. 2018; 39(5):1187-1197.
PMID: 29696467
DOI: 10.1007/s10792-018-0925-z.
Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation.
Neelakantan I, Di Palma S, Smith C, McCoombe A
Head Neck Pathol. 2015; 10(3):354-61.
PMID: 26577210
PMC: 4972744.
DOI: 10.1007/s12105-015-0670-9.
Syndrome in question.
Pousa C, Lavorato F, Rehfeldt F, Mann D, Alves M
An Bras Dermatol. 2015; 90(5):759-61.
PMID: 26560227
PMC: 4631247.
DOI: 10.1590/abd1806-4841.20153193.
p53 staining correlates with tumor type and location in sebaceous neoplasms.
Shalin S, Sakharpe A, Lyle S, Lev D, Calonje E, Lazar A
Am J Dermatopathol. 2012; 34(2):129-35.
PMID: 22441365
PMC: 3313553.
DOI: 10.1097/DAD.0b013e3181ed39f9.
Muir-torre syndrome: a case report.
Higgins H, Voutsalath M, Holland J
J Clin Aesthet Dermatol. 2010; 2(8):30-2.
PMID: 20729952
PMC: 2923964.
Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.
Shalin S, Lyle S, Calonje E, Lazar A
Histopathology. 2010; 56(1):133-47.
PMID: 20055911
PMC: 2805836.
DOI: 10.1111/j.1365-2559.2009.03454.x.
Paraneoplastic dermatological manifestation of gastrointestinal malignancies.
Dourmishev L, Draganov P
World J Gastroenterol. 2009; 15(35):4372-9.
PMID: 19764087
PMC: 2747056.
DOI: 10.3748/wjg.15.4372.
Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.
Dores G, Curtis R, Toro J, Devesa S, Fraumeni Jr J
Cancer. 2008; 113(12):3372-81.
PMID: 18932259
PMC: 2613970.
DOI: 10.1002/cncr.23963.
Sebaceous carcinoma of the skin of the breast: a case report.
Alzaraa A, Ghafoor I, Yates A, Dhebri A
J Med Case Rep. 2008; 2:276.
PMID: 18706083
PMC: 2527503.
DOI: 10.1186/1752-1947-2-276.
Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature.
Tsalis K, Blouhos K, Vasiliadis K, Tsachalis T, Angelopoulos S, Betsis D
World J Surg Oncol. 2006; 4:8.
PMID: 16466577
PMC: 1386670.
DOI: 10.1186/1477-7819-4-8.
Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani S
J Clin Pathol. 2001; 54(9):689-92.
PMID: 11533075
PMC: 1731526.
DOI: 10.1136/jcp.54.9.689.